Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Infectious disease R&D Pipeline

Antiviral, antibacterial, and infectious disease vaccine pipeline programs.

Programs 1,112

Quick answer

Infectious disease: NovaPharmaNews indexes 1,112 infectious disease clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Antiviral, antibacterial, and infectious disease vaccine pipeline programs.

Top sponsors

Pipeline programs

Page 19 of 24

  1. Sporozoite Challenge Model for Plasmodium vivax in Humans

    BRIGHT MINDS BIOSCIENCES INC.

    Malaria, Vivax

    phase 1 mab completed

    1 trial

  2. Sulopenem

    Iterum Therapeutics plc

    Urinary Tract Infections

    phase 1 small molecule terminated

    1 trial

  3. TAF/EVG Vaginal Insert

    United Therapeutics Europe Ltd

    Hiv

    phase 1 small molecule completed

    1 trial

  4. TD-1607

    Theravance Biopharma Ireland Umited

    Serious Infections Due to Known or Suspected Gram-positive Pathogens

    phase 1 small molecule completed

    1 trial

  5. TD-1607

    Theravance Biopharma Ireland Umited

    Infections

    phase 1 small molecule completed

    1 trial

  6. TD-6450

    Theravance Biopharma Ireland Umited

    Hepatitis C

    phase 1 small molecule completed

    2 trials

  7. TI-0010

    BRIGHT MINDS BIOSCIENCES INC.

    COVID-19

    phase 1 mab active

    1 trial

  8. TKM-100201

    Arbutus Biopharma Corp

    Ebola Virus Infection

    phase 1 small molecule terminated

    1 trial

  9. TKM-100802 for Injection

    Arbutus Biopharma Corp

    Ebola Virus Infection

    phase 1 small molecule terminated

    1 trial

  10. TNP-2092 capsules

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    phase 1 small molecule completed

    1 trial

  11. TVB-2640 - 50 mg

    Sagimet Biosciences

    Non-alcoholic Steatohepatitis

    phase 1 small molecule completed

    1 trial

  12. Telaprevir; Moxifloxacin; Placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  13. Treatment sequence AB

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  14. U10-02-11-001

    PDS Biotechnology Corp

    High-risk HPV Infection and Biopsy-proven CIN1

    phase 1 mab completed

    1 trial

  15. UB-421 SC

    United Therapeutics Europe Ltd

    HIV-1-infection

    phase 1 mab active

    1 trial

  16. UB-421 SC(dB4C7C22-6 mAb)

    United Therapeutics Europe Ltd

    HIV-1 Infection

    phase 1 mab completed

    1 trial

  17. UB-621

    United Therapeutics Europe Ltd

    Herpes Simplex Virus Infection

    phase 1 small molecule completed

    1 trial

  18. VCH 916

    Vertex Pharmaceuticals (Australia) Pty.

    HCV Infection

    phase 1 small molecule completed

    1 trial

  19. VCH-222

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  20. VGX-3100

    INOVIO PHARMACEUTICALS, INC.

    Papillomavirus Infections

    phase 1 mab completed

    1 trial

  21. VGX-6150

    INOVIO PHARMACEUTICALS, INC.

    Hepatitis C, Chronic

    phase 1 mab completed

    1 trial

  22. VIR-1111

    Vir Biotechnology

    HIV I Infection

    phase 1 mab completed

    1 trial

  23. VIR-3434

    Vir Biotechnology

    Chronic Hepatitis B

    phase 1 mab completed

    1 trial

  24. VRON-0200-AdC6

    Vir Biotechnology

    Chronic Hepatitis B

    phase 1 mab active

    1 trial

  25. VX-985 or matching placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  26. Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg

    Hospital Authority, Hong Kong

    COVID-19 Pandemic

    phase 1 mab active

    1 trial

  27. Vebicorvir (VBR)

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial

  28. Woman-focused intervention

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 1 other completed

    1 trial

  29. XTL 6865

    XTL BIOPHARMACEUTICALS LTD

    Hepatitis C

    phase 1 small molecule active

    1 trial

  30. XTL-2125

    XTL BIOPHARMACEUTICALS LTD

    Chronic Hepatitis C Virus Infection

    phase 1 small molecule terminated

    1 trial

  31. Yinhu Qingwen Granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Viral Pneumonia

    phase 1 small molecule active

    1 trial

  32. ZFN modified T cells

    SANGAMO THERAPEUTICS, INC

    HIV

    phase 1 mab completed

    1 trial

  33. intraconazole

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis

    phase 1 small molecule completed

    1 trial

  34. routine HIV testing

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 1 other completed

    1 trial

  35. sD-NP-GT8 DNA

    INOVIO PHARMACEUTICALS, INC.

    HIV Infections

    phase 1 mab completed

    1 trial

  36. shenhuang granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    phase 1 small molecule active

    1 trial

  37. telaprevir formulation A

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  38. yimitasvir

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis c

    phase 1 small molecule completed

    1 trial

  39. zelicapavir (therapeutic dose)

    ENANTA PHARMACEUTICALS INC

    RSV Infection

    phase 1 small molecule completed

    1 trial

  40. -

    The George Institute

    Acute lower Respiratory Tract Infection or acute rhinosinusitis

    approved small molecule active

    1 trial

  41. 103900

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  42. 112771

    Disc Medicine

    Fungal infection

    approved small molecule active

    1 trial

  43. 2 doses of HAV

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  44. 201010025M

    Hospital Authority, Hong Kong

    Hepatitis

    approved small molecule active

    1 trial

  45. 2018ZX10721202001002001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab active

    3 trials

  46. 219815

    GlaxoSmithKline

    Respiratory Syncytial Virus Infections

    approved small molecule active

    1 trial

  47. 60 µg dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab completed

    1 trial

  48. 60 µg dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccination

    approved mab completed

    1 trial

Frequently asked questions

How many infectious disease pipeline programs are tracked?

1,112 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.